Geeplus vs Covid-19: Geeplus Continues to Boost Production of Crucial Ventilator Parts

Beckenham, UK / South Carolina, USA - As countries throughout the world work to coordinate administration of various Covid-19 vaccines, Geeplus' expanded production personnel have continued to work around the clock to support the world's top ventilator manufacturers with crucial actuation devices — most notably, our renowned Voice Coil Motors.


The pandemic created an unprecedented demand for a number of Geeplus products—specifically high-precision voice coil motors and solenoids used in ICU ventilator applications. This led to 24-hour production during the height of the pandemic.


The VM38 voice coil motor in particular is an extremely advanced and highly controllable voice coil actuator, that has aided Geeplus in becoming the world's leading supplier of actuators in medical ventilator applications. Learn more in this brief video.

Geeplus Expands; TRIPLES Production Capacity

Demand has remained high for our high-precision actuators. In response, we've doubled the size of our UK manufacturing facility in London. Production capacity has now tripled!


Now, with the majority of production components created and tested in-house, Geeplus is confident that all of our worldwide customers, across a wide range of industries, will benefit from the extended facility!

To request a quote or learn more about your options for an actuator, visit our Request for Quote (RFQ) Form or “Ask an Engineer” page.

Geeplus is a worldwide leader in the design and manufacture of precision electromechanical actuators. You can find Geeplus online at www.geeplus.com, as well as on social media on LinkedIn, Facebook, and YouTube.

Go to article: Home | Can regulators keep up with AI?Go to article: In this issueGo to article: ContentsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: Watlow Company InsightGo to article: WatlowGo to article: BriefingGo to article: Industry newsGo to article: The medical industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: FusetecGo to article: Tricor SystemsGo to article: mdi ConsultantsGo to article: AccumoldGo to article: CommentGo to article: Face masks detecting SARS-CoV-2 are newest weapon to control the pandemicGo to article: Regenerative medicine to drive cartilage repair market to $2bn by 2030Go to article: Covid-19 misinformation circulating on social media can be harmGo to article: Mecmesin Company InsightGo to article: MecmesinGo to article: In DepthGo to article: When opposites attract: the problematic pull of pacemakersGo to article: Can regulators keep up with AI in healthcare?Go to article: Elizabeth Holmes on trial: the case against the Theranos founderGo to article: Will there ever be a test for chronic fatigue syndrome?Go to article: Inside the UK’s PCR price problemGo to article: Simulating the Covid-19 vaccine rolloutGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: TS Quality & EngineeringGo to article: SemecsGo to article: In DataGo to article: Data: medical industryGo to article: The medical industry key listGo to article: Global markets and indicesGo to article: Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: GeeplusGo to article: Smiths InterconnectGo to article: EventsGo to article: Next Issue